Literature DB >> 11494381

The use of vein grafts in the treatment of peripheral lymphedemas: long-term results.

C Campisi1, F Boccardo, A Zilli, A Macció, F Napoli.   

Abstract

This study evaluates long-term results of the treatment of peripheral lymphedemas by the microsurgical reconstructive technique of interposed vein grafts. The technique consists of the use of autologous vein grafts to reconstruct lymphatic pathways where there is a block to the lymphatic circulation of the limb, whether of congenital or acquired etiology. The venous segment represents a sort of "bridge" between afferent and efferent lymphatic collectors (lymphatic-venous-lymphatic plasty [LVLA]). The results also proved to have positive long-term effects after microsurgical operation. Follow-up evaluation was performed clinically by water volumetry and instrumentally by lymphangioscintigraphy. With this LVLA technique, peripheral lymphedemas can be treated when derivative lymphovenous shunts cannot be used because of impaired venous circulation in the same lymphedematous limb. The new aspect of the study is that we report long-term clinical and instrumental results.

Entities:  

Mesh:

Year:  2001        PMID: 11494381     DOI: 10.1002/micr.1027

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  3 in total

1.  Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery.

Authors:  Corradino Campisi; Francesco Boccardo
Journal:  World J Surg       Date:  2004-06       Impact factor: 3.352

Review 2.  Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Authors:  Tessa C Gillespie; Hoda E Sayegh; Cheryl L Brunelle; Kayla M Daniell; Alphonse G Taghian
Journal:  Gland Surg       Date:  2018-08

Review 3.  Tissue-engineered lymphatic graft for the treatment of lymphedema.

Authors:  Muholan Kanapathy; Nikhil M Patel; Deepak M Kalaskar; Afshin Mosahebi; Babak J Mehrara; Alexander M Seifalian
Journal:  J Surg Res       Date:  2014-07-30       Impact factor: 2.192

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.